期刊文献+

依达拉奉治疗急性脑梗死疗效观察 被引量:11

原文传递
导出
摘要 目的观察依达拉奉治疗脑梗死的疗效和安全性。方法 82例脑梗死患者随机分为治疗组与对照组各41例,对照组给予小剂量肠溶阿司匹林、辛伐他汀、川芎嗪、胞二磷胆碱等常规治疗,治疗组在常规治疗基础上给予依达拉奉注射液30mg+生理盐水100mL,2次/d,静脉滴注,2组疗程均为14d,比较2组疗效。结果治疗组总有效率87.80%,显效率63.41%;对照组总有效率53.66%,显效率39.02%,2组治疗有效率、显效率比较差异均有统计学意义(P<0.05)。结论依达拉奉治疗急性脑梗死疗效肯定且安全。
作者 周娟
出处 《中华实用诊断与治疗杂志》 2011年第12期1221-1222,共2页 Journal of Chinese Practical Diagnosis and Therapy
  • 相关文献

参考文献5

二级参考文献15

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 2横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
  • 3Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.
  • 4Kawai H,Nakai H,Misao S,et al.Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].J Pharmacol Exp Ther,1997,281(2)∶921-927.
  • 5Tabrizchi R.Edaravone Mitsubishi-Tokyo[J].Curr Opin Investig Drugs,2000,1(3)∶347-454.
  • 6Yamamoto T,Yuki S,Watanabe T,et al.Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia[J].Brain Res,1997,762(12)∶240-242.
  • 7Watanabe T,Egawa M.Effects of an antistroke agent MCI-186 on cerebral arachidonate cascades[J].J Pharmacol Exp Ther,1994,271(3)∶1624-1629.
  • 8Watanabe T,Morita I,Nishi H,et al.Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro[J].Prostaglandins Leukotrienes Essent Fatty Acids,1998,33(1)∶81-87.
  • 9Mitsumori K,Sakuragi M,Kitami K,et al.The effect MCI-186 on regional cerebral blood flow in patients with acute cerebral infarction-A sequential SPECT study[J].Ther Res,1998,19(4)∶1333-1345.
  • 10山本美奈子 高松康雄.Pharmacokinetic studies of 3—methyl—1—phenyl—2—pyrazolin—5—one(MCI—186):protein binding and distribution to red blood cell[J].药理と治疗,1997,25(17):1755-1763.

共引文献43091

同被引文献81

  • 1田德元.高原地区高血压性脑出血临床特点及治疗(68例分析)[J].高血压杂志,1995,3(4):312-313. 被引量:8
  • 2Nishinaka Y,Mori H,Endo N,et al.EdaraVone directly reacts with singlet oxygen and protects cells from attack[J].Life Sci,2010,86(21-22):808-813.
  • 3Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008;22:311-314.
  • 4Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neuro12009; 256:1152-1158.
  • 5Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neuro12008; 21: 639-643.
  • 6Loubinoux I, Chollet F. Neuropharmacology in stroke recovery. In: Cramer SC, Nudo R J, eds. Brain repair afer stroke. Cambridge: Cambridge University Press, 2010, 183-193.
  • 7Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect.Neurosci Res 2009; 87:1037-1045.
  • 8Li WL, Cai HI-I, Wang B, et al. Chronic fluoxetine treatment improves ischemia- induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 2009; 87:112-122.
  • 9Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiplegic patients undergoing rehabilitation trerapy. Stroke. 1996; 27(7):1211-1214.
  • 10Chollet F, Tardy J, Albucher JF, et al.Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.Lancet Neurol. 2011 Feb; 10(2):123~130. Epub 2011 Jan 7.

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部